Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient

被引：0
|
作者：
A. N. Aravindan
Venkatesh Moger
Vinay Sakhuja
Harbir S. Kohli
Neelam Varma
Vivekanand Jha
机构：
[1] Postgraduate Institute of Medical Education and Research,Departments of Nephrology
[2] Hematology,undefined
[3] Postgraduate Institute of Medical Education and Research,undefined
来源：
International Urology and Nephrology | 2006年 / 38卷
关键词：
Kidney transplantation; Posttransplant lymphoproliferative disorder; Hepatitis C; Immunosuppression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Posttransplant lymphoproliferative disorders (PTLD) are commonly caused by Ebstein-Barr Virus infection. The role of hepatitis C virus (HCV) in the genesis of lymphomas has been recognized recently. We report a HCV infected renal transplant recipient who developed PTLD 11 months after transplantation. Reduction of immunosuppression led to disappearance of viremia and clearance of PTLD. This is the first such report in the world literature.
引用
收藏
页码：355 / 357
页数：2
相关论文
共 50 条
  • [21] Post Transplant Lymphoproliferative Disorder
    Gupta, Devika
    Mendonca, Satish
    Chakraborty, Sushmita
    Chatterjee, Tathagata
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2020, 36 (02) : 229 - 237
  • [22] Post Transplant Lymphoproliferative Disorder
    Devika Gupta
    Satish Mendonca
    Sushmita Chakraborty
    Tathagata Chatterjee
    Indian Journal of Hematology and Blood Transfusion, 2020, 36 : 229 - 237
  • [23] Hepatitis B and C in the liver transplant recipient
    Rosen, HR
    Martin, P
    SEMINARS IN LIVER DISEASE, 2000, 20 (04) : 465 - 480
  • [24] The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure
    Morales, JM
    Domínguez-Gil, B
    Sanz-Guajardo, D
    Fernández, J
    Escuin, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 : 72 - 76
  • [25] FIBROSING CHOLESTATIC HEPATITIS IN A RENAL-TRANSPLANT RECIPIENT ASSOCIATED WITH THE HEPATITIS-B VIRUS PRECORE MUTANT
    BOOTH, JCL
    GOLDIN, RD
    BROWN, JL
    KARAYIANNIS, P
    THOMAS, HC
    JOURNAL OF HEPATOLOGY, 1995, 22 (04): : 500 - 503
  • [26] Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients
    Sampaio, Marcelo Santos
    Cho, Yong W.
    Shah, Tariq
    Bunnapradist, Suphamai
    Hutchinson, Ian V.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (07) : 2971 - 2979
  • [27] Hepatitis C virus infection in renal transplant patients: a comparative study with immunocompetent patients
    Perez, RM
    Ferreira, ASP
    Silva, ISS
    Medina-Pestana, JO
    Lanzoni, VP
    Silva, AEB
    Ferraz, MLG
    CLINICAL TRANSPLANTATION, 2005, 19 (06) : 763 - 768
  • [28] Remission of Epstein-Barr virus-positive post-transplant lymphoproliferative disorder by conversion to everolimus in a kidney transplant recipient
    Nanmoku, Koji
    Shinzato, Takahiro
    Kubo, Taro
    Shimizu, Toshihiro
    Yagisawa, Takashi
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (04)
  • [29] Hepatitis C virus-associated pericardial effusion and tamponade in a liver transplant recipient
    Nikolaidis, LA
    Azzouz, M
    Friedlander, L
    Van Thiel, DH
    Gradman, AH
    CANADIAN JOURNAL OF CARDIOLOGY, 2004, 20 (07) : 719 - 721
  • [30] Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study
    Hosseini-Moghaddam, S. M.
    Alhomayeed, B.
    Soliman, N.
    Weir, M. A.
    House, A. A.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (03) : 423 - 430
12345